Clinical Practice Guidelines
2.0.0-ballot - ballot International flag

Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of and changes regularly. See the Directory of published versions

ActivityDefinition: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

Active as of 2023-12-19

Generated Narrative: ActivityDefinition

Resource ActivityDefinition "cc-cpg-activity-referral-nephrology"

Profile: CPG Computable Activity Definition

CQF Knowledge capability: shareable

CQF Knowledge capability: computable

CQF Knowledge capability: publishable

CQF knowledge representation level: structured

StructureDefinition Work Group: cds


version: 2.0.0-ballot

name: ReferralNephrology

title: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

status: active

experimental: true

date: 2023-12-19 06:22:49+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support:

description: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

jurisdiction: World (m49.htm#001)


type: justification

display: Refer to nephrologist for co-management of treatment plan in cases of: Unclear etiology of kidney disease Rapid progression of disease (GFR decline greater than 5 mL/minute/1.73 m²/year) Acute kidney injury or abrupt sustained fall in GFR GFR less than 30 mL/minute/1.73 m² (GFR categories G4-G5) to prepare for renal replacement therapy Consistent finding of significant albuminuria (albumin/creatinine ratio of 300 mg/g or more) Hypertension resistant to treatment with 4 or more antihypertensive agents Difficulty in decreasing the level of albuminuria despite institution of ACE inhibitor or angiotensin II receptor blocker therapy Persistent electrolyte abnormalities, including hyperkalemia or high serum phosphate Recurrent or extensive nephrolithiasis Hereditary kidney disease   Nephrologist involvement is recommended when the cause of chronic kidney disease is not clear Renal biopsy may be performed to determine the cause as well as to predict disease progression and response to therapy

citation: Chronic Kidney Disease Clinical Overview. ClinicalKey. Source



kind: ServiceRequest

code: Referral to nephrologist (SNOMED CT#306286007 "Referral to nephrologist (procedure)")

intent: proposal

timing: Events: Now()